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Exposure of protein kinase C to low concentrations of either N-chlorosuccinimide or H202 resulted in rapid 
and parallel loss of phosphotransferase activity and phorbol ester binding. This oxidative inactivation of 
protein kinase C also occurred in intact cells exposed to a low concentration of H202. With H202 treatment 
the rate of inactivation of protein kinase C in the cytosol of MCF-7 cells was rather slower than that which 
occurred in the cytosol of PYS cells. However, in both cell types, the oxidative inactivation of membrane- 
associated protein kinase C occurred rapidly in comparison to the enzyme in the cytosol. Prior treatment 
of cells with phorbol ester to induce membrane association (stabilization) of protein kinase C, followed by 
exposure to HzOz, resulted in increased inactivation of protein kinase C, suggesting that membrane associa- 
tion of protein kinase C increases its susceptibility to oxidative inactivation 
Protein kinase C; Oxidative inactivation; Oxygen radical; Phorbol ester; Membrane binding 
1. INTRODUCTION 
Ca*+- and phospholipid-dependent protein 
kinase C plays a crucial role in the signal transduc- 
tion of a variety of extracellular stimuli and also 
serves as an intracellular receptor for tumor pro- 
moter phorbol esters [1,2]. Tumor promoter treat- 
ment of cells has been shown to generate reactive 
oxygen species which appear to play a major role 
in the process of tumor promotion [3]. Oxidative 
inactivation has been reported for a number of 
proteins including Ca*+ -regulated calmodulin and 
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troponin C [4,5]. Loss of both protein kinase C ac- 
tivity and phorbol ester binding in cells treated for 
prolonged periods of time with phorbol esters has 
been reported [6-S]. While proteolytic degrada- 
tion of the activated enzyme does occur in several 
cell types [6-81, other mechanisms might also be 
involved in this inactivation process. Here, we 
show that protein kinase C both in the isolated 
form and in the intact cells is highly susceptible to 
oxidative inactivation upon exposure to hydroxyl 
radicals (OH’). This inactivation results in the loss 
of both phosphotransferase activity and phorbol 
ester binding. 
2. MATERIALS AND METHODS 
N-Chlorosuccinimide and Hz02 (30%, w/w) 
were obtained from Sigma. The concentration of 
Hz02 was standardized by using the spec- 
trophotometric method of Luck [9]. Protein kinase 
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C was partially purified from bovine brain as 
described [lo] and enzyme having an activity of ap- 
prox. 400 U/mg protein was used. The protein 
kinase C preparation was dialyzed to remove 
2-mercaptoethanol present in the buffer prior to 
oxidative modification. Laboratory water (reverse 
osmosis) was further passed through a deionizer 
and an activated-charcoal unit to remove traces of 
N-chloramines present. Protein was estimated by 
the procedure of Lowry et al. [l I] using bovine 
serum albumin as the standard. 
PYS and MCF-7 cells were grown in DMEM 
medium supplemented with 10% fetal calf serum 
in 150-cm* flasks. Cytosolic and membrane frac- 
tions were prepared from confluent cells and pro- 
tein kinase C was isolated from these fractions by 
DEAE-cellulose chromatography as in [lo]. Pro- 
tein kinase C activity was assayed using histone Hl 
as substrate [10,12] and phorbol ester binding was 
measured using [3H]PDBu as ligand [ 131. Only the 
stimulated activity observed in the presence of 
Ca*+ and phospholipid was expressed as units of 
protein kinase C activity (1 nmol phosphate 
transferred to histone Hl/min at 30°C). 
Calmodulin, calpain and protein kinase A were 
measured as described [ 14- 161. 
3. RESULTS AND DISCUSSION 
N-Chlorosuccinimide is a mild oxidizing agent 
which modifies oxidation-susceptible surface 
amino acid residues in proteins [ 171. When 
purified protein kinase C was treated with a low 
concentration (10 PM) of N-chlorosuccinimide for 
5 min, about 40% of protein kinase C activity was 
lost. Exposure of the enzyme to increasing N- 
chlorosuccinimide concentrations up to 100 FM 
resulted in a progressive loss in phosphotransferase 
activity (fig. 1A). At 100 PM, N-chlorosuccinimide 
caused about 50% loss of enzyme activity within 
30 s, and all activity was lost after 5 min of treat- 
ment (fig.lB). As shown in fig.1, this oxidation 
treatment also resulted in a parallel loss of 
[3H]PDBu binding. This suggests either that 
catalytic and phorbol ester-binding sites have the 
same degree of susceptibility to oxidation or that 
these two sites are influenced by a common 
oxidation-susceptible domain in the enzyme. Pro- 
tein kinase C was inactivated when stored (at 4°C) 
in the absence of reducing agents in buffers 
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Fig.1. Oxidative inactivation of protein kinase C by N- 
chlorosuccinimide. Purified protein kinase C (approx. 
1 U) was treated with the indicated concentrations of N- 
chlorosuccinimide for 5 min (A) or 1OOpM N- 
chlorosuccinimide for the indicated time periods (B) and 
dithiothreitol was then added to a final concentration of 
10 mM to prevent further inactivation. Aliquots of the 
treated samples were assayed for both protein kinase C 
phosphotransferase activity (M) and [‘H]PDBu 
binding (O---O). 
prepared with regular laboratory-supplied (reverse 
osmosis) water, apparently due to traces of N- 
chloramines. No loss in activity was noted if the 
water used was processed to remove N- 
chloramines as described in section 2. 
The oxidatively inactivated protein kinase C ex- 
hibited neither phosphotransferase activity nor 
phorbol ester binding even when the concentra- 
tions of components (histone Hl, ATP, 
phospholipids, and PDBu) used in the assay reac- 
tion mixtures were increased by IO-times the stan- 
dard amount. This suggests that the observed 
losses in activity and PDBu binding after oxidative 
modification were not due to decreased affinity for 
these ligands. Even without modification at the 
catalytic site, alterations of the lipid/phorbol- 
binding domains alone could result in a decrease in 
Ca*+- and phospholipid-stimulated activity. 
Hence, we subjected modified protein kinase C to 
limited proteolysis using trypsin or calpain II to 
release active catalytic fragment free of the 
regulatory portion of the molecule. However, no 
increase in Ca*+/phospholipid-independent activi- 
ty was found. Even the M-kinase (Ca*+/phos- 
pholipid-independent form) derived from native, 
unmodified protein kinase C by limited proteolysis 
[ 121, was inactivated with exposure to low concen- 
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trations of N-chlorosuccinimide suggesting that 
both the catalytic and phorbol ester-binding 
domains of protein kinase C are susceptible to oxi- 
dative modification. 
Protein kinase C was also inactivated with ex- 
posure to a low concentration (5 mM) of Hz02 for 
only a few minutes. This inactivation was 
prevented by the addition of scavengers of OH’ 
radicals, mannitol (100 mM) and N-acetylcysteine 
(100 mM), suggesting that the OH’ radicals form- 
ed from Hz02 were involved. This oxidative inac- 
tivation of protein kinase C by OH’ radicals may 
be of regulatory significance since OH’ and other 
reactive oxygen species are formed in cells under 
certain physiological and pathological conditions. 
Several agents such as chemotactic factors (N- 
formyl-methionyl-leucyl-phenylalanine), tumor 
promoters and anticancer drugs (adriamycin) are 
known to generate various reactive oxygen species 
including OH’ radicals [ 171. 
While a number of enzymes are inactivated in 
vitro by reactive oxygen species, only a few en- 
zymes are inactivated by these radicals in intact 
cells as there are several scavenger mechanisms 
operative to protect the cell from oxygen toxicity 
[18]. Further, the binding of endogenous ligands 
can mask oxidation-susceptible sites thereby pro- 
tecting some proteins from inactivation. Thus, we 
tested whether oxidative inactivation of protein 
kinase C can be observed in intact cells exposed to 
a low (5 mM) concentration of H202. As shown in 
fig.2A, protein kinase C activity decreased in both 
membrane and cytosol within a few minutes 
following exposure of intact PYS cells to Hz02 and 
no activity was detectable after 30 min of treat- 
ment. The inactivation of membrane-bound pro- 
tein kinase C was found to be more rapid under 
these conditions. With MCF-7 cells, about 75% of 
membrane-associated protein kinase C activity was 
lost within 30 min of exposure to 5 mM Hz02 
(fig.2B). In contrast, there was little change in 
cytosolic protein kinase C activity with treatment 
of intact MCF-7 cells with 5 mM Hz02 for time 
periods up to 30 min. However, by raising the con- 
centration of Hz02 used to treat MCF-7 cells to 
15 mM, cytosolic protein kinase C also was inac- 
tivated, although at a slower rate than that noted 
for the loss of membrane-associated activity. 
Under all these conditions described the loss of 
protein kinase C activity correlated with a cor- 
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Fig.2. Oxidative inactivation of protein kinase C in 
intact cells treated with HzO2. PYS (A) and MCF-7 (B) 
cells (4-6 x 10’) were treated with either 5 or 15 mM 
Hz02 as noted at 37°C for the indicated time intervals. 
Protein kinase C activity present in the cytosolic and 
detergent-solubilized membrane fractions was 
determined. 
responding decrease in [3H]PDBu binding (table 
1). 
The relatively rapid inactivation of protein 
kinase C in the membrane fraction might be due to 
enhanced lipid peroxidation by OH’ radicals. 
Lipid peroxidation (chain reaction) in turn can 
generate other reactive oxygen species [ 191. Alter- 
natively, the membrane-bound protein kinase C 
may be in a form with increased susceptibility to 
oxidation. Most probably, the cytosolic protein 
kinase C in MCF-7 cells might be protected by 
catalase, glutathione peroxidase and other 
scavenger mechanisms which may be less operative 
in PYS cells. Although calmodulin is oxidatively 
inactivated in the isolated form [4,5], no inactiva- 
tion of this protein occurred in H202-treated intact 
cells under these conditions (unpublished). 
Similarly, other related enzymes like Ca2+-acti- 
vated protease (calpain) and CAMP-stimulated 
protein kinase A were also not inactivated under 
these conditions suggesting that high susceptibility 
to oxidative inactivation may be limited to few en- 
235 
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Table 1 
Loss of [3H]PDBu binding in PYS and MCF-7 cells 
treated with Hz02 
Cell type Treatment [3H]PDBu binding 
(pmol) 
Cyto- 
sol 
Mem- 
brane 
PYS cells control 0.8 0.5 
5 mM HzO2, 10 min 0.3 0.1 
5 mM HzOz, 30 min 0 0 
MCF-7 cells control 5.3 3.1 
5 mM H202, 10 min 5.1 1.4 
5 mM H202, 30 min 5.4 0.8 
15 mM H202, 10 min 3.2 0.1 
15 mM H202, 30 min 0.2 0 
Both PYS cells (6 x 10’) and MCF-7 cells (4 x 10’) were 
treated with low (5 mM) and high (15 mM) Hz02 
concentrations for the indicated periods of time. Protein 
kinase C present in the cytosolic and membrane 
fractions was isolated by DEAE-cellulose chromatog- 
raphy as described in section 2 and [3H]PDBu binding 
was then determined 
zymes such as protein kinase C in intact cells. 
Since phorbol esters induce the redistribution of 
protein kinase C from cytosol to plasma mem- 
brane [10,20,21], we investigated whether this shift 
in protein kinase C from cytosol to membrane 
leads to increased inactivation of protein kinase C 
upon exposure to low concentrations (5 mM) of 
Hz02 (table 2). As previously noted in fig.2B, ex- 
posure of control (not treated with TPA) MCF-7 
cells to 5 mM Hz02 caused only a slight change in 
cytosolic protein kinase C activity, such that total 
(membrane plus cytosolic) activity was decreased 
by only 25% under these conditions (table 2). 
However, with MCF-7 cells pretreated with TPA 
for 1 h to enhance protein kinase C association 
with membranes, exposure to 5 mM Hz02 resulted 
in a much greater (60%) loss in total protein kinase 
C activity, again accounted for by inactivation of 
the enzyme associated with the membrane frac- 
tion. This further indicates that membrane binding 
of protein kinase C increases its susceptibility to 
oxidative inactivation. 
The disappearance of protein kinase C (both ac- 
tivity and immunoreactive protein) in cells treated 
for prolonged (24 h) periods with TPA has been 
reported [6-81. It has been postulated that calpain- 
mediated proteolysis of membrane-bound enzyme 
may be responsible for this desensitization [6-81. 
In addition to promoting the association of protein 
kinase C with membranes [10,20,21], TPA can 
also promote the formation of reactive oxygen 
radicals [3]. TPA treatment has also been shown to 
decrease the activity of scavenger enzymes like 
superoxide dismutase and catalase [22]. In view of 
the present results which demonstrate increased 
susceptibility of membrane-bound protein kinase 
C to oxidative inactivation, it is conceivable that 
increased oxidative inactivation of protein kinase 
Table 2 
Susceptibility of TPA-induced membrane-associated protein kinase C to oxidative 
inactivation 
Treatment Protein kinase C activity [3H]PDBu binding 
(units) (pmol) 
Cytosol Membrane Total Cytosol Membrane Total 
Control 4.1 1.5 5.6 4.9 3.3 8.2 
TPA (1 h) 1.5 3.7 5.2 1.8 6.9 8.7 
5 mM Hz02 3.9 0.3 4.2 5.1 0.9 6.0 
TPA followed by 
5 mM Hz02 1.7 0.6 2.3 1.6 1.5 3.1 
Confluent MCF-7 cells (4 x 10’) were treated with 100 nM TPA for 1 h where 
indicated and then both TPA-treated and control cells were exposed to 5 mM Hz02 
for 30 min 
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C may occur in TPA-treated cells. This may occur 
in addition to, or along with, proteolytic inactiva- 
tion. In fact, oxidatively modified proteins have 
been reported to show enhanced susceptibility to 
proteolysis [23]. 
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